Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Methods and Biostatistics in Oncology (eBook)

Understanding Clinical Research as an Applied Tool
eBook Download: PDF
2018 | 1st ed. 2018
XII, 348 Seiten
Springer International Publishing (Verlag)
978-3-319-71324-3 (ISBN)

Lese- und Medienproben

Methods and Biostatistics in Oncology -
Systemvoraussetzungen
96,29 inkl. MwSt
(CHF 93,95)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
This book introduces and discusses the most important aspects of clinical research methods and biostatistics for oncologists, pursuing a tailor-made and practical approach.
Evidence-based medicine (EBM) has been in vogue in the last few decades, particularly in rapidly advancing fields such as oncology. This approach has been used to support decision-making processes worldwide, sparking new clinical research and guidelines on clinical and surgical oncology. Clinical oncology research has many peculiarities, including specific study endpoints, a special focus on survival analyses, and a unique perspective on EBM. However, during medical studies and in general practice, these topics are barely taught. Moreover, even when EBM and clinical cancer research are discussed, they are presented in a theoretical fashion, mostly focused on formulas and numbers, rather than on clinical application for a proper literature appraisal.
Addressing that gap, this book discusses more practical aspects of clinical research and biostatistics in oncology, instead of relying only on mathematical formulas and theoretical considerations. Methods and Biostatistics in Oncology will help readers develop the skills they need to understand the use of research on everyday oncology clinical practice for study design and interpretation, as well to demystify the use of EBM in oncology.


Raphael L. C. Araujo is a Surgical Oncologist specialized in the diagnosis and treatment of malignant and benign injuries of the liver, pancreas and colorectal liver metastases. He spent two years (2010 / 2012) as a Research Fellow at the Hepatopancreatobiliary Service of the Memorial Sloan-Kettering Cancer Center in New York (USA). During this time, he worked on clinical research of surgical and systemic treatment of pancreatic cancer and colorectal liver metastases. Afterwards, he also spent one year as a resident of the Hepatopancreatobiliary Service at the Hospital Paul Brousse, France (2012/2013). Dr. Araujo received a PhD and concluded his postdoctoral research in Gastroenterology from the University of São Paulo School of Medicine, the same institution where he worked for 2 years as an attending physician in the Liver Surgery Unit. He is currently head of the Department of Upper Gastrointestinal and Hepato-Pancreato-Biliary Surgery and Professor of the Post Graduation Program of Barretos Cancer Hospital, Barretos, São Paulo, Brazil, and Scientific Director of Brazilian Society of Surgical Oncology.

Rachel P. Riechelmann is a medical oncologist and researcher in the field of gastrointestinal cancers. She completed her formal training and PhD at the Federal University of Sao Paulo, followed by a clinical research fellowship at Princess Margaret Hospital, University of Toronto, Canada. She is currently the Director of the Department of Oncology at AC Camargo Cancer Center,  which is one of the largest academic cancer centers in Brazil and Latin America, and Research Director of the Brazilian Gastrointestinal Tumors Group. Research- wise, her areas of interest and expertise are GI malignancies and Neuroendocrine Tumors as well as Methodology of Clinical Research. She has 78 publications in peer-reviewed journals and several PhD students and oncology fellows conducting projects under her supervision. 

Raphael L. C. Araujo is a Surgical Oncologist specialized in the diagnosis and treatment of malignant and benign injuries of the liver, pancreas and colorectal liver metastases. He spent two years (2010 / 2012) as a Research Fellow at the Hepatopancreatobiliary Service of the Memorial Sloan-Kettering Cancer Center in New York (USA). During this time, he worked on clinical research of surgical and systemic treatment of pancreatic cancer and colorectal liver metastases. Afterwards, he also spent one year as a resident of the Hepatopancreatobiliary Service at the Hospital Paul Brousse, France (2012/2013). Dr. Araujo received a PhD and concluded his postdoctoral research in Gastroenterology from the University of São Paulo School of Medicine, the same institution where he worked for 2 years as an attending physician in the Liver Surgery Unit. He is currently head of the Department of Upper Gastrointestinal and Hepato-Pancreato-Biliary Surgery and Professor of the Post Graduation Program of Barretos Cancer Hospital, Barretos, São Paulo, Brazil, and Scientific Director of Brazilian Society of Surgical Oncology.Rachel P. Riechelmann is a medical oncologist and researcher in the field of gastrointestinal cancers. She completed her formal training and PhD at the Federal University of Sao Paulo, followed by a clinical research fellowship at Princess Margaret Hospital, University of Toronto, Canada. She is currently the Director of the Department of Oncology at AC Camargo Cancer Center,  which is one of the largest academic cancer centers in Brazil and Latin America, and Research Director of the Brazilian Gastrointestinal Tumors Group. Research- wise, her areas of interest and expertise are GI malignancies and Neuroendocrine Tumors as well as Methodology of Clinical Research. She has 78 publications in peer-reviewed journals and several PhD students and oncology fellows conducting projects under her supervision. 

PrefaceAuthor: Mithat Gönen – chief of biostatistics department of Memorial Sloan-Kettering Cancer Center – NY – USA.Background of scientific method in oncologyAuthor: Vinícius Vazquez – Surgical oncologist – Barretos Cancer Hospital, Barretos, São Paulo, BrazilWriting a hypothesis for a oncology studyAuthor: Felipe Fregni, Harvard Medical SchoolType of variables and distributionsAuthor: Gregory Pond, MacMaster, Hamilton, ON, CanadaTesting measures of associationAuthor: To be definedSample size calculation for oncology trialsAuthor: Ulrich Güller, Kantonsspital St. Gallen, 9007, St Gallen, Switzerland. ulrich.gueller@kssg.chUni and multivariate analysis (understanding of regressions) in cancer researchAuthor: Marc Buyse, EORTC Survival analyses in cancer trialsAuthor: Daniel Sargent, Mayo ClinicThe role of transversal and cohort studies in oncologyAuthor: To be definedDesign of retrospective and case-control studies in oncologyAuthor: To be definedMinimizing differences by randomizationAuthor: To be definedHow to design phase I trials in oncologyAuthor: Lillian Siu, Princess Margert Hospital, Toronto, ON, Canada ou Carlos Gil, INCAThe many different designs of phase II oncology trialsAuthor: Gilberto de Castro e Paulo Hoff?Superiority and non-inferiority phase III oncology trialsAuthors: Everardo Saad, (affiliation TBD)Phase IV oncology trials Author:Analysis of graphs in clinical cancer researchAuthor: Raphael Araujo – Upper GI and HPB Surgery department;  Barretos Cancer Hospital, Barretos, SP, BrazilIdentifying biases in clinical cancer researchAuthor: Rachel Riechelmann, Instituto do Cancer do Estado de Sao Paulo, Universidade de São PauloEthics in clinical cancer researchAuthor: Rodrigo GuidaliniCost-effectiveness studies in oncologyAuthor: Ian Tannock, Princess Margert Hospital, Toronto, ON, CanadaHow to undertake outcomes research in oncologyAuthor: Christopher Booth,  NCI Canada, Kingston, ONSystematic review and meta-analysis of oncology studiesAuthor: André SasseMeta-research in oncologyAuthor: Everardo SaadAnalysis of quality of life and patient-reported outcomes in oncologyAuthor: Janette Vardy, University of Sidney, AustraliaExercisesCommented answersGlossary

Erscheint lt. Verlag 16.4.2018
Zusatzinfo XII, 348 p. 58 illus., 37 illus. in color.
Verlagsort Cham
Sprache englisch
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Technik
Schlagworte Biostatistics • clinical research • Methodology • Methods • Oncology • outcomes • Research
ISBN-10 3-319-71324-8 / 3319713248
ISBN-13 978-3-319-71324-3 / 9783319713243
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 6,3 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Entstehung, Progression und Therapie von Krebs

von Christoph Wagener; Oliver Müller

eBook Download (2022)
Thieme (Verlag)
CHF 195,35
Entstehung, Progression und Therapie von Krebs

von Christoph Wagener; Oliver Müller

eBook Download (2022)
Thieme (Verlag)
CHF 195,35
Handbuch für die Pflegepraxis

von Thomas Kroner; Anita Margulies; Sacha Rothschild …

eBook Download (2023)
Springer Berlin Heidelberg (Verlag)
CHF 29,30